Calls for proposals

CEPI funds and partners with organisations to accelerate the development of vaccines against emerging infectious diseases.

About our calls for proposals

CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates.

Open calls for proposals

OPEN: Expression of Interest: Vaccine Drug Products in alternative primary packaging and delivery devices

Learn more Close

Past calls for proposals

COVID-19 vaccine development
Vaccine platform technologies for rapid response against SARS-CoV-2

Learn more Close

Platform technologies to rapidly respond to Disease X

Learn more Close

COVID-19: COVAX Civil Society & Community Representation

Learn more Close

COVID-19 vaccines: Sterility testing during dispensing from multidose Drug Product bag

Learn more Close

Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19

Learn more Close

COVID-19: Accelerating vaccine development and global manufacturing capacity to stop the pandemic

Learn more Close

ACT Accelerator COVAX Pillar - Independent Product Group

Learn more Close

Proven vaccine technologies, applicable for large scale manufacturing, for rapid response against novel coronavirus, 2019-nCoV

Learn more Close

Expression of Interest: Sponsor and CRO for clinical trials with COVID-19 candidate vaccines

Learn more Close

Centralized laboratory for measurement of immune responses elicited by SARS-CoV-2 vaccine candidates

Learn more Close

Extension of Original Scope: Centralized laboratory for measurement of immune responses elicited by SARS-CoV-2 vaccine candidates (Phase III and beyond)

Learn more Close

Supply of Elastomeric Closures and Aluminum Overseals for the COVID-19 vaccines

Learn more Close

Vaccines, Platform Technologies and clinical trials
Call for Proposals 3 (CfPi) applicants - Human vaccine development against Rift Valley fever and Chikungunya diseases

Learn more Close

Vaccine development against Lassa, MERS and Nipah

Learn more Close

Platform technologies to enable rapid vaccine development against novel pathogens

Learn more Close

Vaccines against Lassa virus disease – Joint call with the European and Developing Countries Clinical Trials Partnership (EDCTP)

Learn more Close

Biological standards and assays
Rift Valley Fever: Sourcing of serum from recovered patients for the development of a Rift Valley Fever (RVF) international antibody standard

Learn more Close

Biological standards to support and accelerate Lassa fever vaccine development

Learn more Close

Data collection
Request for Information on rapid-response platform technologies for epidemic preparedness

Learn more Close

Scientific research
Preparing for Lassa vaccine trials with targeted epidemiology studies

Learn more Close

Ebola survivor data

Learn more Close